ANIP

ANI Pharmaceuticals Inc.

HealthcareDrug Manufacturers - Specialty & GenericUnited StatesNASDAQ

$85.61

+1.15%today

MKT CAP

$1.9B

+10.0% · 1Y

Full Financials

Trailing P/E25.3x

Forward P/E7.9x

EV/EBITDA-

Price/Sales-

Dividend Yield-

Revenue Growth YoY-

Earnings Growth YoY-

Revenue Growth QoQ+8.4%

5y Revenue CAGR+40.8%

5y Earnings CAGR-

Gross Margin-

Operating Margin-

Net Margin-

ROE-

Debt / Equity-

Free Cash Flow-

Insider Ownership7.4%

Institutional Ownership100.1%

Short % of Float18.73%

Days to Cover10.1d

1 Week+7.5%

1 Month-

3 Months-

6 Months-

YTD-

1 Year-

3 Years-

5 Years-

vs 50-day SMA-

vs 200-day SMA-

vs 52w High-

vs 52w Low-

Peers

Ticker	Cap	Score	P/E	Fwd P/E	EV/EBITDA	ROE	Gross	D/E	Div
AMLX Amylyx Pharmaceuticals Inc. Common Stock	$1.8B	-	-	-	-	-	-	-	0.00%
BHC Bausch Health Companies Inc. Common Stock	$2.1B	100	-	1.4	-	-	-	-	0.00%
PRGO Perrigo Company plc Ordinary Shares	$1.7B	100	-	5.0	-	-	-	-	990.00%
BCRX BioCryst Pharmaceuticals Inc. Common Stock	$2.3B	80	-	11.7	-	-	-	-	0.00%
HCM HUTCHMED (China) Limited American Depositary Shares	$2.3B	67	5.0	25.5	-	-	-	-	0.00%
PAHC Phibro Animal Health Corporation Class A Common Stock	$2.3B	51	19.1	12.7	-	-	-	-	82.00%